Blog
RSS FeedPosted by Michael Wonder on 26 Aug 2022
Government secures monkeypox medicine, PHARMAC working on getting vaccines
26 August 2022 - The Government has secured monkeypox medicine which is expected to be available in New Zealand from ...
Posted by Michael Wonder on 22 Aug 2022
Monkeypox vaccines not expected until December
20 August 2022 - Monkeypox vaccines aren't expected to arrive in New Zealand until December, according to PHARMAC. ...
Posted by Michael Wonder on 06 Aug 2022
New Zealand allowed pharmacists to dispense COVID-19 antivirals and 'everyone realised it was a win'
6 August 2022 - With Australians dying from COVID-19 every day and nearly 5,000 people in hospital with the disease, experts ...
Posted by Michael Wonder on 26 Jul 2022
45 medicines affected by supply issues as COVID causes 'unprecedented challenge'
27 July 2022 - In the past month, New Zealand has been hit by medicine supply issues affecting large swathes ...
Posted by Michael Wonder on 21 Jul 2022
Aotearoa less affected by medicine supply issues than other countries
22 July 2022 - PHARMAC’s work behind the scenes and unique arrangements with suppliers means New Zealand has been less ...
Posted by Michael Wonder on 29 Jun 2022
Accuretic supply issue, almost 36,000 New Zealanders taking the blood pressure medicine will need to change treatments
30 June 2022 - PHARMAC has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier ...
Posted by Michael Wonder on 27 Apr 2022
Arthritis patients suffer after medication diverted due to COVID-19
27 April 2022 - Rheumatoid arthritis sufferers have been left in pain as one of their medications was diverted for ...
Posted by Michael Wonder on 31 Mar 2022
PHARMAC secures advance purchase agreement for a pre-exposure COVID-19 treatment
31 March 2022 - PHARMAC has negotiated an agreement with AstraZeneca for its pre-exposure prophylactic COVID-19 treatment, which would be targeted ...
Posted by Michael Wonder on 30 Mar 2022
Pfizer’s oral COVID-19 treatment arrives in New Zealand
31 March 2022 - The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New ...
Posted by Michael Wonder on 27 Jan 2022
Shortage of prescription infant formula worries parents
28 January 2022 - A shortage of prescription infant formula has parents worried about how they will feed their babies. ...
Posted by Michael Wonder on 06 Dec 2021
PHARMAC negotiates deal with Pfizer for its promising new oral antiviral treatment for COVID-19
6 December 2021 - PHARMAC has negotiated an agreement with Pfizer for its promising new oral anti-viral treatment to treat ...
Posted by Michael Wonder on 07 Nov 2021
COVID-19: PHARMAC confident with growing stock of drugs to treat virus
7 November 2021 - PHARMAC is growing increasingly confident it is getting close to having enough of the drugs needed to ...
Posted by Michael Wonder on 10 Oct 2021
PHARMAC negotiates deal for molnupiravir to treat COVID-19
11 October 2021 - PHARMAC has negotiated an agreement with supplier MSD to purchase the antiviral molnupiravir. ...
Posted by Michael Wonder on 14 Sep 2021
Limiting the impact on Kiwis as API leaves the NZ market
14 September 2021 - PHARMAC is working hard to limit the impact on over 1 million Kiwis who currently take ...
Posted by Michael Wonder on 06 Sep 2021
New Zealand’s tocilizumab supply to be paused
6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New ...